{"disease":{"id":"preclinical-alzheimer-s-disease","name":"preclinical alzheimer s disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06033066","title":"Financial Incentives and Recruitment to the APT Webstudy","phase":"NA","overall_status":"COMPLETED","enrollment_count":44844,"lead_sponsor_name":"University of Southern California","has_results":false},{"nct_id":"NCT04468659","title":"AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate Amyloid","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1400,"lead_sponsor_name":"Eisai Inc.","has_results":false},{"nct_id":"NCT06957418","title":"Alzheimer's Tau Platform: Master Protocol","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":900,"lead_sponsor_name":"Paul S. Aisen","has_results":false},{"nct_id":"NCT07167966","title":"Alzheimer's Tau Platform: Regimen A - AADvac1","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":450,"lead_sponsor_name":"Paul S. Aisen","has_results":false},{"nct_id":"NCT03370744","title":"Prediction of Cognitive Decline by Neuroimaging Techniques and the Application in Diagnosis and Treatment of Preclinical AD","phase":"","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"XuanwuH 2","has_results":false},{"nct_id":"NCT04004767","title":"TRC-PAD Program: In-Clinic Trial-Ready Cohort","phase":"","overall_status":"COMPLETED","enrollment_count":220,"lead_sponsor_name":"University of Southern California","has_results":false},{"nct_id":"NCT04828122","title":"Amyloid Prediction in Early Stage Alzheimer's Disease From Acoustic and Linguistic Patterns of Speech","phase":"","overall_status":"COMPLETED","enrollment_count":141,"lead_sponsor_name":"Novoic Limited","has_results":false},{"nct_id":"NCT06956300","title":"TMS for Cognitive Decline in Aging and Preclinical AD","phase":"NA","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT04851496","title":"Amyloid Prediction in Early Stage Alzheimer's Disease From Acoustic and Linguistic Patterns of Speech - PAST Extension","phase":"","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"Novoic Limited","has_results":false},{"nct_id":"NCT04928976","title":"Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping","phase":"","overall_status":"COMPLETED","enrollment_count":67,"lead_sponsor_name":"Novoic Limited","has_results":false},{"nct_id":"NCT04846426","title":"Amyloid Prediction in Early Stage Alzheimer's Disease From Acoustic and Linguistic Patterns of Speech - FUTURE Extension","phase":"","overall_status":"TERMINATED","enrollment_count":67,"lead_sponsor_name":"Novoic Limited","has_results":false},{"nct_id":"NCT07158905","title":"AV-1980R (Tau Vaccine) in Preclinical Alzheimer's Disease (TAURUS-1980)","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":48,"lead_sponsor_name":"Institute for Molecular Medicine","has_results":false},{"nct_id":"NCT04951284","title":"Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping - FUTURE Extension","phase":"","overall_status":"TERMINATED","enrollment_count":42,"lead_sponsor_name":"Novoic Limited","has_results":false},{"nct_id":"NCT04937959","title":"Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping - PAST Extension","phase":"","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"Novoic Limited","has_results":false},{"nct_id":"NCT02963415","title":"Concurrent Aerobic Exercise and Virtual Reality Cognitive Training","phase":"NA","overall_status":"COMPLETED","enrollment_count":39,"lead_sponsor_name":"University of Minnesota","has_results":false},{"nct_id":"NCT07142278","title":"DUVAX: A Phase 1 Alzheimer's Vaccine Study Targeting Amyloid-Beta and Tau","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":24,"lead_sponsor_name":"Nuravax, Inc.","has_results":false}],"total":16},"guidelines":[],"source":"Drug Landscape verified database"}